Eli Lilly won approval for its tirzepatide under the names Mounjaro for type 2 diabetes and Zepbound for weight loss -- in ...

SAN FRANCISCO, Jan 13 () - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug ...

Eli Lilly and NVIDIA have unveiled a first-of-its-kind AI co-innovation lab, aiming to solving the most complex bottlenecks ...

In another AI win for Google lately, Apple announced on Monday that it will use Google’s Gemini models to power its ...

A veteran FDA regulator who left last month said the firewall between agency political appointees and drug reviewers “has ...

NVIDIA and Eli Lilly launch a $1 billion AI lab to speed drug discovery, improve manufacturing, and apply artificial ...

Obesity took center stage on the first day of the 2026 J.P. Morgan Healthcare Conference, with industry frontrunners Eli ...

Drug discovery costs have always been high. Nvidia claims its AI can reduce costs by 70%, backed by a $1B partnership with ...

NVIDIA, Alphabet, and Amazon have emerged as the top three "Magnificent Stocks" based on a combination of growth metrics, valuation, and strategic market positioning. Each company offers a unique ...

Investors weigh Fed independence concerns after probe involving chair and geopolitical tensions, while tech and defense stock ...

Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding ...

Eli Lilly (LLY) is teaming up with Nvidia (NVDA) to invest in an artificial intelligence (AI) innovation lab. Eli Lilly CFO ...